Early ezetimibe initiation after myocardial infarction significantly lowers cardiovascular events compared to delayed or no combination lipid-lowering therapy.

Patients suffering from myocardial infarction who receive early add-on lipid-lowering medication have a significantly better prognosis than those who ...

People with a certain heart valve abnormality are at increased risk of severe heart rhythm disorders, even after successful valve surgery. This is according to a new study, "Mitral annular disjunction ...

Analysis suggests that treating heart attack patients earlier with a combination of statins and the cholesterol-lowering drug ezetimibe could prevent thousands of new heart attacks over a decade.

Giving patients a combination of drugs earlier in their treatment could prevent thousands of heart attacks, according to a ...

Patients suffering from myocardial infarction who receive early add-on lipid-lowering medication have a significantly better ...

Cardiovascular disease is by far the most common cause of death worldwide, and myocardial infarction is the most common acute event.

Cardiovascular disease is by far the most common cause of death worldwide, and myocardial infarction is the most common acute ...

Patients who get an add-on medication soon after a heart attack have a better prognosis than those who receive it later, or ...

A major new study shows that giving heart attack patients a cholesterol-lowering combo treatment early on – not months later – can dramatically improve their outlook and even save lives. Patients trea ...